热门资讯> 正文

BeyondSpring GAAP每股收益为-0.02美元

2026-08-17 16:32

万春医药(BYSI) 0

BeyondSpring press release (BYSI): Q2 GAAP EPS of -$0.02.
Net loss was $1.8 million for the quarter ended June 30, 2026, compared to $1.9 million for the quarter ended June 30, 2025.
Cash, cash equivalents, and short-term investments were $6.5 million as of June 30, 2026, compared to $12.6 million as of December 31, 2025.

More on BeyondSpring

Historical earnings data for BeyondSpring
Financial information for BeyondSpring

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。